Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tenecteplase in Wake-up Ischaemic Stroke Trial (TWIST). A Randomised-controlled Trial of Thrombolytic Treatment With Tenecteplase for Acute Ischaemic Stroke Upon Awakening

NCT03181360 is registered in ClinicalTrials.gov with University Hospital of North Norway as lead sponsor.

NCT NCT03181360
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03181360 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tenecteplase in Wake-up Ischaemic Stroke Trial (TWIST). A Randomised-controlled Trial of Thrombolytic Treatment With Tenecteplase for Acute Ischaemic Stroke Upon Awakening
Lead sponsor
University Hospital of North Norway
Phase
Phase 3
Overall status
Unknown status
Start date
June 12, 2017
Completion date
December 31, 2022
Enrollment
600 (estimated)
Sites
83

Conditions

As the registry lists them; a condition with its own page is linked.

ischemic stroke, stroke, acute